On December 4, 2024, the China Veterinary Medical Association (CVMA) officially released seven group standards, including the "Real-time Fluorescent RAA Assay for Feline Parvovirus." The release of these standards marks a critical breakthrough in the application of Recombinase Aided Amplification (RAA) technology within the veterinary field, significantly advancing its popularization and acceptance.
Among them, Xunling Biotech, in collaboration with the College of Animal Science and Technology & College of Veterinary Medicine of Zhejiang A&F University and Zhejiang Lead-Bio Technology Co., Ltd., participated in drafting two RAA technical group standards: "Fluorescent RAA Detection Method for Five Pathogens of Feline Respiratory Syndrome" and "Fluorescent RAA Detection Method for Six Pathogens of Canine Respiratory Syndrome."
RAA technology has gained widespread adoption in nucleic acid testing due to its advantages of requiring no complex equipment, simple operation, rapid detection, and high sensitivity. As an industry leader in RAA technology, Xunling Biotech is committed to its development and promotion, achieving remarkable results. The release of these standards not only affirms the effectiveness of RAA technology in the veterinary field but also recognizes Xunling's technical capabilities and market positioning.
We will continue to deepen collaboration with industry associations and research institutions to promote the application of RAA technology in more veterinary diagnostic areas and actively participate in the development and refinement of industry standards. Through continuous innovation and optimization, we aim to provide robust technical support for the digital and intelligent transformation of the veterinary industry.
。